Sitemap Contact Privacy Statement Imprint

Invited Speakers

 
2017    
24.05.2017 Joerg Albert, MD
Robert-Bosch-Hospital
Physiology and pathophysiology of the digestive system (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”)
31.05.2017 Christian Schäfer, MD
Robert-Bosch-Hospital
Physiology and pathophysiology of the liver (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”)
31.05.2017 Jun J. Yang, Ph.D.
St. Jude Children's Research Hospital
Pharmacogenomics of Thiopurines and Precision Medicine: From Genomics to Clinical Actions
14.06.2017 Godehard Friedel, MD
Robert-Bosch-Hospital - Schillerhoehe
Physiology and pathophysiology of the lungs (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”)
21.06.2017 Andreas Hartkopf, MD
University Hospital Tuebingen
Physiology and pathophysiology of the breast (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”) (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”)
28.06.2017 Kilian Rapp, MD
Robert-Bosch-Hospital
Physiological Specialties in Elderly Patients (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”)
05.07.2017 Peter Ong, MD
Robert-Bosch-Hospital
Physiology and pathophysiology of the cardiovascular System (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”)
13.07.2017 Robert Feil, PhD
University of Tuebingen
Seeing is believing: Combining biochemistry and mouse genetics to visualize physiology, pathophysiology and pharmacology
12.07.2017 Martin Kimmel, MD
Robert-Bosch-Hospital
Physiology and pathophysiology of the kidneys (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”)
19.07.2017 Andreas Nüssler, MD
University of Tuebingen
Cell culture approaches towards 3D micro-organ Engineering (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”)
18.09.2017 Sven Glaesker, MD
University Hospital Brussels
Molecular and morphological pathogenesis in von Hippel-Lindau (VHL) disease
08.11.2017 Klaus Moerike, MD
University Hospital Tuebingen
Arzneimitteltherapie kardialer Arrhythmien (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”)
15.11.2017 Robert Lukowski, PhD
University Hospital Tuebingen
The NO-cGMP system: Implications for disease biology and therapy
22.11.2017 Reinhold Kerb, MD
CRS Clinical Research GmbH
Drug Therapy of Diabetes, Obesity, Metabolic Syndrome (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”)
29.11.2017 Peter Muenzel
University of Tuebingen
Gifte und Vergiftungen (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”)
08.12.2017 Carsten Gruellich, MD
NCT -National Center for Tumor Diseases Heidelberg Medical Oncology
Molekulare Heterogenität und therapiegetriebene Evolution des Nierenzellkarzinoms
11.12.2017 Markus Morkel, MD
Charité - University Hospital Berlin
Organoids as a tool to assess oncogene characteristics and cancer signaling networks
13.12.2017 Robert Juette, PhD
Institute of the History of Medicine, Robert Bosch Stiftung
Der Placebo Effekt: Past and Present (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”)
 
2016    
04.05.2016 Walter Aulitzky, MD
Robert-Bosch-Hospital
Introduction – Basic and Clinical Aspects (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”)
22.06.2016 Michael Schwarz, MD
University Hospital Tuebingen
Mechanisms of Tumor Promotion (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”)
23.06.2016 Elfriede Nößner, PhD
Helmholtz- Center Munich
“Enriched-in-renal-carcinoma dendritic cells” (ercDCs) are unique macrophages with a gene signature indicative of immune escape
29.06.2016 German Ott, MD
Robert-Bosch-Hospital
Tumor Pathology – Where Morphology Meets Molecular Genetics (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”)
29.06.2016 Joachim Orth, PhD
University of Freiburg
Regulation of bone cell differentiations by G protein deamidating toxins
13.07.2016 Michael Dengler, PhD
The Walter & Eliza Hall Institute of Medical Research, Victoria, Australia
Control of apoptosis by the Bcl-2 family: Molecular mechanisms and therapeutic potential (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”)
29.07.2016 Hannelore Daniel, PhD
Technical University Munich (TUM)
We are all individuals – I am not
03.08.2016 Daniela Stöhr, PhD
University of Stuttgart
Downregulation of TRAIL receptor expression in multicellular tumor spheroids: a reason for TRAIL resistance?
26.10.2016 Christina Justenhoven, PhD
Bioscientia – Insititute of Medical Diagnostics, Ingelheim
Analysis of DNA Variations (Part of the PhD Curriculum with focus on ”Molecular and cell-biology methodology and selected “soft-skills” topics”)
23.11.2016 Marius Ueffing, PhD
Medical Proteome Center Tübingen
Proteomics – From basic approaches to clinical applications
20.12.2016 Barbara Seliger, PhD
Martin Luther University, Halle
How tumor cells escape immune resistance
21.12.2016 H.P. Rodemann, PhD
University Hospital Tübingen
Soft Dkills I: Good scientific practice (Part of the PhD Curriculum with focus on ”Molecular and cell-biology methodology and selected “soft-skills” topics”)
 
2015    
03.02.2015 Edgar Serfling, PhD
University of Wuerzburg
NFATc1 Controls the Fate of Lymphocytes by Controlling their Metabolic Capacity
04.02.2015 Peter Münzel, PhD
University Hospital Tuebingen
Gifte und Vergiftungen
11.02.2015 Klaus Mörike, MD
University Hospital Tuebingen
Drug Therapy in Special Populations: Pregnancy and Old Age
18.02.2015 Christian Harteneck, PhD
University Hospital Tuebingen
Pharmacological Mudulation of Ion Channels
16.03.2015 Jörn Lausen, PhD
Georg-Speyer-Haus, Frankfurt
Epigenetic mechanisms in hematopoiesis as molecular therapeutic targets
24.04.2015 Monica Campillos, PhD
Helmholtz-Zentrum München
From pertubations of mammalian organisms to phenotypes
04.11.2015 Marieke Coenen, PhD and Maroeska te Loo, PhD
Radboud University Medical Center, Nijmegen
Pharmacogenetics of inflammatory bowel disease and childhood cancer: from research to diagnostics
09.12.2015 Klaus Mörike, MD
University Hospital Tübingen
Clinical Studies – Design and Realization
2014
22.01.2014 Thomas Wheeler-Schilling, PhD
University Hospital Tübingen
What a scientist should know beyond science
28.01.2014 Steven de Jong, PhD
Dept. of Medical Oncology, University Medical Center Groningen
Targeting novel pathways to overcome platinum-based resistance in testicular and ovarian cancer
20.02.2014 Dik van Gent, MD, PhD
Erasmus Universiteit Rotterdam, Netherlands
Exploiting the DNA damage response for personalized tumor treatment
09.05.2014 Gerhard Treiber, MD
Gastro Zentrum Hirslanden Klinik, Schänisweg, Aarau, Switzerland
Physiology and Pathophysiology of Oesophagus and Stomach
14.05.2014 Christian Schäfer, MD
Gastroenterology, Robert-Bosch-Hospital, Stuttgart
Physiology and Pathophysiology of the liver
23.05.2014 Ali Yilmaz, MD
Cardiology, University Hospital Münster
Physiology and Pathophysiology of the Cardiovascular System
11.06.2014 Godehard Friedel, MD
Klinik Schillerhöhe
Physiology and Pathophysiology of the lungs
09.07.2014 Niko Braun, MD
Robert-Bosch-Hospital, Stuttgart
Physiology and Pathophysiology of the kidneys
15.07.2014 Sara Y. Brucker, MD
Medical Director, Dept. of Female Health, University Hospital Tuebingen
Physiology and Pathophysiology of the breast
27.10.2014 Margarida D. Amaral, PhD
BioISI, Faculty of Sciences, University of Lisboa, Portugal
Cystic Fibrosis: Novel Personalized Therapies Targeting the Molecular Defect
29.10.2014 Klaus Mörike, MD
Dept. of Clinical Pharmacology, University Hospital Tuebingen
Drug Treatment of Cardiac Arrhythmia
12.11.2014 Robert Jütte, Dr. phil.
Institute of the History of Medicine, Stuttgart 
The Placebo Effect: Past and Present
19.11.2014 Ulrich Lauer, MD
Dept. Internal Medicine I, University Hospital Tuebingen
Virotherapie therapiefraktärer Tumorerkrankungen
21.11.2014 Björn Windshügel, PhD
Fraunhofer Institut, Hamburg 
Computational Approaches in Nuclear Receptor Research
26.11.2014 Walter Aulitzky, MD
Dept. of Oncology, Robert-Bosch-Hospital
Anticancer Drugs - Mechanisms and Therapy
04.12.2014 Julia Schüler
Oncotest GmbH, Freiburg 
Oncology Platforms at Oncotest
10.12.2014 Reinhold Kerb, MD
Medical Director, CRS Clinical Research GmbH, Lübeck
Drug Therapy of Diabetes, Obesity, Metabolic Syndrome
2013
07.01.2013 Dr. Matthias Haag
Institute of Genetics, University of Cologne
Quantification of Mitochondrial Phospholipids by ESI-MS/MS
18.01.2013 Monilola Olayioye, PhD
Institute of Cell Biology and Immunology, University of Stuttgart
ErbB receptors: Novel regulatory mechanisms and signaling crosstalk
23.01.2013 Stephan Urban, PhD
Department of Molecular Virology, University Hospital Heidelberg
Entry and entry inhibition of Hepatitis B virus (HBV): The role of sodium taurocholate co-transporting polypeptide (NTCP/SLC10A) as a functional HBV receptor
18.02.2013 Friedrich Pürner, MD
Women's penitentiary, Aichach
Medizin hinter Gittern - Alltag ärztlicher Arbeit im Knast
17.04.2013 Walter Aulitzky, MD
Robert-Bosch-Hospital, Stuttgart
Introduction - Basic and Clinical Aspects in Oncology
24.04.2013 German Ott, MD
Robert-Bosch-Hospital, Stuttgart
Tumor Pathology
15.05.2013 Christoph Ulmer, MD
Robert-Bosch-Hospital, Stuttgart
Importance of visceral surgery in metastasis
29.05.2013 Birgit Spänkuch, MD
University Hospital Tübingen
The role of Plk1 for the cell cycle in cancer and primary cells
19.06.2013 Michael Schwarz, MD
University Hospital Tübingen
Mechanisms of tumor promotion
19.07.2013 Saskia de Wildt, MD, PhD
Dept. of Surgery and Intensive Care, Erasmus MC Sophia Children's Hospital
Drug metabolism in children: the interplay of age, disease and genetics
24.10.2013 Nico Scheer / John Bial
Taconic GmbH, Cologne and Yecuris Portland, USA
Genetically and liver humanized mouse models and advanced human hepatocytes for improved prediction of the ADMET characteristics of compounds in humans
06.11.2013 Christina Justenhoven, PhD
Bioscientia, Institute of Medical Diagnostics, Ingelheim
Analysis of DNA variations
26.11.2013 Kerstin Junker, MD
University Hospital Saarland
Molekulargenetische Charakterisierung des Nierenzellkarzinoms zur individuellen Prognosedifferenzierung und Therapiewahl
2012
11.01.2012 Prof. Klaus Mörike
Clinical Pharmacology, University Hospital Tübingen
Drug Therapy in Special Populations: Advanced Age and Pregnancy
18.01.2012 Prof. Klaus Mörike
Clinical Pharmacology, University Hospital Tübingen
Drug Therapy of Cardiac Arrhytmia
19.01.2012 Dario Cattaneo, PhD
Unit of Clinical Pharmacology, "Luigi Sacco" University Hospital, Milan, Italy
Clinical Pharmacology of antiretroviral drugs
24.01.2012 Ludmilla Prokunina-Olsson, PhD
Laboratory of Translational Genomics, National Cancer Institute, NIH, Bethedsda, USA
Genetics of cellular detoxification and its role in bladder cancer susceptibility - the mysterious case of the UGT1A locus
15.02.2012 Adriano Henney, PhD
Program Director of the German Virtual Liver Network
Systems approaches to 21st Century Medicine
22.02.2012 Prof. Jörn Lötsch
Hospital and Faculty of Medicine, Johann Wolfgang Goethe-University, Frankfurt / Main
Drug therapy against pain: pharmacokinetics, pharmacogenetics, and drug development
23.03.2012 Prof. Dr. Werner Mewes
Helmholtz Zentrum München; Deutsches Forschungszentrum für Gesundheit und Umwelt
Systems Biology from Correlation to Causation for Personalized Medicine
23.04.2012 Prof. Dr. Marc Reymond
Marienhospital Herne, Klinikum der Ruhr-Universität Bochum
Normotherme Intraperitoneale Aerosol Chemotherapie (NIPAC): ein neuer Ansatz in der Therapie der Peritonealkarzinose
03.05.2012 Prof. Dr. Swen Hülsmann
Universitätsmedizin Göttingen
Neuron-Glia-Interaction: Are brainstem astrocytes different?
29.05.2012 Dr. Ute Albrecht
Universitätsklinikum Düsseldorf
Crosstalk of mediators: Communication between macrophages and hepatocytes
05.06.2012 Prof. Dr. Andreas J. Fallgatter
Ärztlicher Direktor der Klinik für Allgemeine Psychiatrie und Psychotherapie mit Poiklinik, Eberhard Karls Universität Tübingen
Brain functional endophenotypes in Attention Deficit- / Hyperactivity Disorder - a pathway to individualized psychiatry?
09.10.2012 Dr. Susann Irgang
Max Planck Institut für Molekulare Pflanzenphysiologie, Golm
Metabolic regulation during the inhibition of the 'Target of rapamycin' Kinase in Chlamydomonas reinhadtii
29.10.2012 Dipl. Biochem. Stefanie Schmidt
Max Planck Institut für Molekulare Pflanzenphysiologie, Golm
Reil mediated leaf development in the cold
29.11.2012 Prof. Dr. Guenter Schwarz
Institute of Biochemistry, Department of Chemistry & Center for Molecular Medicine, University of Cologne
Biochemistry of Molybdenum: Pathways, Enzymes, and neurodegenerative Diseases
11.12.2012 Dr. Florian Schröder
Max Planck Institut für Molekulare Pflanzenphysiologie, Golm
Brassinosteroid-dependet leaf growth
2011
19.01.2011 PD Dr. Peter Bauer
Medical Genetics, University of Tuebingen
Next Generation-Sequencing for DNA and RNA.
09.02.2011 Prof. Dr. Peter Jansen
Department of Hepatology, Academic Medical Center, Amsterdam, The Netherlands
Multidrug Resistance Transporters and miRNAs Expression in Hepatocellular Carcinoma.
06.04.2011 PD Dr. Susanne Ammon-Treiber
Clinical Pharmacology, University Hospital Tübingen
The isolated perfused lung as a model in lung pharmacology.
29.06.2011 Dr. Niko Braun
Robert-Bosch-Hospital, Stuttgart
Physiology and Pathophysiology of the kidney.
13.07.2011 Prof. Dr. Tanja Fehm
University Women's Hospital, Tübingen
Physiology and Pathophysiology of the breast.
05.08.2011 Prof. Dr. Leszek Wojnowski
University Hospital, Johanns Gutenberg-University Mainz
CYP3As and their regulators - lessons from the past.
22.09.2011 Dr. Nico Scheer
Head of ADMET R&D, TaconicArtemis GmbH, Köln
Humanized mouse models for pharmacokinetic and safety profiling of compounds.
16.11.2011 Prof. Dr. Robert Jütte
Director of the Insitute for the History of Medicine of the Robert Bosch Foundation, Stuttgart
The Placebo Effect: Past and Present
23.11.2011 Dr. Petra Knupfer
Head of the office of the Ethics Committee at the State Medical Chamber of Baden-Wuerttemberg, Stuttgart
Composition and tasks of Research Ethics Committees (RECs).
28.11.2011 Prof. Luc Pellerin
Directeur a.i., Department of Physiology, University of Lausanne, Switzerland
Nuroenergetics: regulations and roles of monocarboxylate transporters
05.12.2011 Dr. Peter Stopfer
Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach
Pharmacokinetics in Drug Development
07.12.2011 Prof. Christian Harteneck
Deputy Head of the Department of Pharmacology and Experimental Therapy (APET), University of Tuebingen
Pharmacological modulation of ion channels
14.12.2011 Dr. Sebastian Graf von Kielmansegg
University of Mannheim, Department of German and Foreign Public Law, International Law and European Law
Legal Regulation of clinical Studies
2010
08.03.2010 Dr. Carina Hellberg
Ludwig Institute for Cancer Research, Uppsala, Sweden
T-cell protein tyrosie phophatase regulates the M2 pyruvate kinase activity.
31.03.2010 Dr.-Ing. Jürgen Friedmann
Vice-President Corporate Intellectual Property Patents Electronics, Robert Bosch GmbH
Von der Idee zum Patent
27.05.2010 Dr. Manfred Rauh
University Hospital Erlangen
LC-MS/MS in der Steroidanalytik
25.10.2010 Prof. Dr. Dietrich Keppler
German Cancer Research Center (DKFZ), Heidelberg
Uptake and Efflux Transporters of Human Hepatocytes.
2009
28.01.2009 Prof. Dr. med. Martin Wehling
University Hospital Mannheim
Nutzenanalyse in Deutschland: Götterdämmerung oder weiter so?
29.01.2009 Univ.-Prof. Dr. med. Karsten Schrör
University Hospital Düsseldorf
Pharmakokinetik und Antiplättchenwirkung von Thienopyridine
23.03.2009 Prof. Dr. med. Martina Muckenthaler
University Hospital Heidelberg
Regulation of systemic iron homeostasis by miR122a
05.05.2009 Prof. Michael S. Phillips, Ph.D
Université de Montréal
Development and optimization of a broad-based ADME genotyping system in clinical trials
12.05.2009 Dr. med. Lusine Danielyan
University Hospital Tübingen
Intranasal delivery of cells to the brain
26.10.2009 Dr. med. Andreas Benesic
Prof. Dr. Alexander L. Gerbes
University Hospital Munich Großhadern
Metaheps - interessante Zellen aus peripheren Monozyten
29.10.2009 Dr. Jan Korbel
European Molecular Biology Laboratory, Heidelberg
Global mapping of coy-number variants in humans - approaches and applications
10.12.2009 Dr. Carole Devaux, Ph.D.
University of Luxembourg
Collaboration with Africa for HIV and AIDS: Challenges and Opportunities
2008
17.01.2008 Prof. Ramiro Jover
University of Valencia, Spain
Regulation of human cytochrome P450 genes by liver-enriched transcription factors: Application to the development of metabolically competent hepatic cell models
20.02.2008 PD Dr. Lütjohann
University of Bonn
Steroidal Marker of Cholesterol and Bile Acid Metabolism
05.03.2008 Prof. Dr. Alfons Meindl
University Hospital 'rechts der Isar', Munich
Monogen, heterogen, polygen - Genetische Formen des familiären Mammakarzinoms
29.04.2008 Prof V. Craig Jordan
Fox Chase Cancer Center, Philadelphia, USA
Development and Current Role of Tamoxifen and Raloxifen in the Treatment or Prevention of Breast Cancer and Osteoporosis
11.06.2008 Dr. Hajo Otten, Patent Lawyer
Witte, Welle & Partner, Stuttgart
Patente und geistiges Eigentum in Medizin und Biotechnologie - eine Einführung
24.06.2008 Prof. Dr. Werner Lubitz
Universitäy of Vienna, Austra
Bacterial Ghost Platform Technology
09.07.2008 Prof. Jens Schröder
University of Schleswig-Holstein
Antimicrobial Peptides: Local Host Response Elements
17.07.2008 Dr. Rene Krieg
Bruker Daltronik GmbH
MALDI Imaging, Molecular Histology and Class Imaging – Novel Techniques for Tissue Based Proteomics
18.07.2008 Prof. Paavo Honkakosi
University of Kuopio, Finland
Unraveling the ligand specificity of nuclear receptor CAR
09.09.2008 Prof. Lutz Heide
University of Tübingen
Genetic engineering of microorganisms for the generation of new antibiotics
15.09.2008 Dr. Jörg Lippert
Bayer Technology Services GmbH
Mechanistische Modellierung und Ihre Anwendungen in der klinischen Pharmakologie
29.09.2008 Professor Amin Rostami-Hodjegan
University of Sheffield, UK
Systems Pharmacology: Putting Things Together
10.10.2008 Prof. Jose Pedro Gil
Karolinska Institute, Sweden
Artemisin derivative combination therapy – a malaria chemotherapy under global implementation
17.10.2008 Prof. Meinhard Kieser
University Hospital Heidelberg
Fallzahlberechnung unter Unsicherheit - Welche Möglichkeiten bieten flexible Studiendesigns?